Animalcare Group, a York-based animal health business, has acquired a 25% strategic equity stake in InVetro, an Australian-based Companion Animal health business for £1.4m.
InVetro will utilise the funds to accelerate investment in scaling its commercial footprint, expanding its product portfolio and developing its new product pipeline, with an agreed pathway to increased ownership by Animalcare over time.
The strategic investment expands Animalcare’s presence in the growing Asia-Pacific veterinary market, building on its acquisition of Randlab completed in January 2025.
InVetro is a development-stage Australian veterinary pharmaceutical company committed to advancing Companion Animal care.
Jenny Winter, CEO of Animalcare, said: “This strategic investment expands the Group’s geographic footprint in the large and growing Companion Animal health market.
“The Australian market presents a significant opportunity, and this partnership allows us to participate in that growth with a trusted and capable team already on the ground. We look forward to supporting the business as it transitions into full-scale commercial operations and begins to maximise its potential.”
Corinne Mawson and Zoe Chrysopoulos, directors and founders of InVetro, said: “At InVetro, our mission is to drive innovation in veterinary care and bring next level solutions to clinics across Australia. Our partnership with Animalcare will provide the opportunity to accelerate our portfolio and expand our market penetration.”
